Wellcome and UKRI have brought together a consortium of leading centres of protein engineering and production to allow UK scientists to access protein reagents needed for critical research relating to SARS-CoV-2 free of charge.
The COVID-19 Protein Portal (CPPC) contains a searchable database of reagents, including viral proteins, human proteins and antibodies relevant for SARS-CoV-2 biology. Each reagent is annotated with key information, including sequence, origin, and SDS-page results.
Researchers select the proteins they require from the database and submit their request with a short research proposal. All requests will be subject to rapid peer review, to enable the CPPC to coordinate and prioritise reagent allocation based on scientific merit and the urgency of the request.
Once approved, a request will be allocated to one of the CPPC’s expert protein production laboratories, all of whom are committed to providing high-quality reagents as quickly as possible.
In the spirit of open science, recipient labs will be required to provide feedback to the CPPC on their results, and to share important outcomes with the scientific community.